Abnormal Findings in Polysomnographic Recordings of Patients with Spinocerebellar Ataxia Type 2 (SCA2)
- 55 Downloads
Spinocerebellar ataxia type 2 (SCA2) is characterized by a progressive cerebellar syndrome, and additionally saccadic slowing, cognitive dysfunction, and sleep disorders. The aim of this study was to assess the frequency of abnormal findings in sleep recordings of patients with SCA2. Seventeen patients with genetically confirmed SCA2 from the Movement Disorders Outpatient group of the Hospital de Clínicas da UFPR were evaluated with a structured medical interview and the Scale for the Assessment and Rating of Ataxia (SARA). Polysomnographic recordings were performed and sleep stages were scored according to standard criteria. There were 10 male subjects and 7 females, aged 24–66 years (mean 47.44). A sex- and age-matched control group of healthy subjects was used for comparison. There was a reduction of rapid eye movement (REM) sleep in 12 (70.58%), increased REM latency in 9 (52.94%), increased obstructive sleep apnea-index in 14 (82.35%), absent REM density (REM density was calculated as the total number of 3-s miniepochs of REM sleep with at least 1 REM per minute) in 13 (76.47%), and markedly reduced REM density in 4 (23.52%). There was an indirect correlation according to the SARA scale and the REM density decrease (r = − 0.6; P = < 0.001); and with a disease progression correlating with a reduction in the REM density (r = − 0.52, P = 0.03). In SCA2, changes occur mainly REM sleep. The absence/decrease of REM sleep density, even in oligosymptomatic patients, and the correlation of this finding with disease time and with the SARA scale were the main findings of the study.
KeywordsSCA SCA2 Spinocerebellar ataxia Spinocerebellar ataxia 2 Sleep disorders REM sleep disorder REM density Polysomnography
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflicts of interest.
- 3.Deppont C, Donatello S, Rai M, Wang FC, Manto M, Simonmis N, et al. MME mutation in dominant spinocerebellar ataxia with neuropathy (SCA43). Neurol Genet. 2016;2:1–6.Google Scholar
- 4.Didonna A, Opal P. Advances in sequencing technologies for understanding hereditary ataxias. JAMA Neurol. 2016;17:1–6.Google Scholar
- 6.Machado de Castilhos RM, Furtado GF, Gheno TC, Schaeffer P, Russo A, Barsottini O, et al. Spinocerebellar ataxias in Brazil—frequencies and modulating effects of related genes on behalf of Rede Neurogenetica. Cerebellum. 2014;13(1):17–28. https://doi.org/10.1007/s12311-013-0510-y.CrossRefGoogle Scholar
- 12.Velázquez-Pérez L, Rodríguez-Labrada R, Canales-Ochoa N, Montero JM, Sánchez-Cruz G, Aquilera-Rodríquez R, et al. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study. Lancet Neurol. 2014;13(5):482–9. https://doi.org/10.1016/S1474-4422(14)70027-4.CrossRefGoogle Scholar
- 19.Rueda AD, Pedroso JL, Truksinas E, Prado GF, Coelho FM, Barsottini OG. Polysomnography findings in spinocerebellar ataxia type 6. J Sleep Res. 2016. https://doi.org/10.1111/jsr.12439.
- 21.Moro A, Munhoz RP, Moscovich M, Arruda WO, Raskin S, Silveria-Moryama L, et al. Nonmotor symptoms in patients with spinocerebellar ataxia type 10. Cerebellum. 2017;6. https://doi.org/10.1007/s12311-017-0869-2.
- 25.American Academy of Sleep Medicine. The manual for the scoring o sleep and associated events:rules, Terminology and technical specifications; 2007.Google Scholar
- 26.American Academy of Sleep Medicine. The manual for the scoring o sleep and associated events: rules, Terminology and Technical Specifications, version 2.3, 2016.Google Scholar
- 29.Tuin I, Voss U, Kang JS, Kessler K, Rüb U, Nolte D, et al. Stages of sleep pathology in spinocerebellar ataxia type 2 (SCA2). Neurology. 2006;67(11):1966–72. https://doi.org/10.1212/01.wnl.0000247054.90322.14.CrossRefGoogle Scholar
- 31.American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien: American Academy of Sleep Medicine; 2014.Google Scholar